Abstract Background and Purpose ZK 200775 is a selective competitive AMPA receptor antagonist. It has demonstrated neuroprotective efficacy in experimental models of stroke and tolerability in healthy volunteers. We tested the safety and tolerability of ZK 200775 in patients with acute ischaemic stroke. Methods In a multicentre double-blind, randomised, placebo-controlled phase II trial, 61 ischaemic [...]